[2]
Gaulin A. Process of treating milk or similar liquids. US Patent
753792, 1904.
[17]
Tarara T, Weers J. Pharmaceutical formulation with an insoluble
active agent. US Patent 20040156792A1, 2004.
[24]
Yadav KS, Kale K. High pressure homogenizer in pharmaceuticals: Understanding its critical processing parameters and applications. J Pharm Inn 2019; 1-12.
[35]
Dhankhar P. Homogenization fundamentals. Int Org Sci Res J Eng 2014; 4(5): 1-8.
[41]
Al-hilphy AR, Verma DK, Niamah AK, Billoria SU, Srivastar P. Principles of ultrasonic technology for treatment of milk and milk
products. Food process engineering: Emerging trends in research
and their applications. CRC press apple academic press 2016; pp.
178-202.
[42]
Benjakul S, Ali AMM, Singh A. Innovative technologies in sea food processing Application of ultrasonication in food processing. New York: CRC press 2020; pp. 131-49.
[43]
Bosiljkov T, Tripalo B. Brnčić M, Jezek D, Karlovic S, Jagust I. Influence of high intensity ultrasound with different probe diameter on the degree of homogenization (variance) and physical properties of cow milk. Afr J Biotechnol 2011; 10(1): 34-41.
[44]
Brzeczko AW, El Saleh F, Yang J. Granulation of poorly water
soluble drugs. Handbook of pharmaceutical granulation technology.
Taylor & Francis group LLC 2016; pp. 381-6.
[47]
Heilenz SJ, Heile SJG. Mortar and pestle for grinding and mixing.
US Patent 3524599A, 1970.
[50]
Kumar R. Lipid-based nanoparticles for drug-delivery systems Nanocarriers for drug delivery. Elsevier 2019; pp. 249-84.
[59]
Burden DW. Guide to the homogenization of biological samples. Random Primers 2008; 7: 1-14.
[61]
Santos JA, Otero A, Lapez MLG. Molecular detection of foodborne
pathogens. Plesiomonas. Taylor and Francis group LLC 2010; pp.
405-16.
[64]
Beg S, Hasnain S, Rahman M, Swain S. Pharmaceutical quality by design: Principles and applications Introduction to Quality by Design (QbD): Fundamentals, principles and applications. Academic press 2019; pp. 1-16.
[67]
Yong AP, Islam MA, Hasan NA. Review: Effect of pressure on homogenization. Sigma J Eng Nat Sci 2017; 35(1): 1-22.
[71]
Keck C. Nanocrystals and amorphous nanoparticles and method for
production of the same by a low energy process. EP Patent
2583672A1, 2013.
[75]
Panyam J, Chavanpatil MD. Lipid-derived nanoparticles for braintargeted
drug delivery. US Patent 20100076092A1, 2010.
[82]
Mohsin ME, Shrivastava NK, Basar N, Arsad A, Hassan A. The effect of sonication time on the properties of electrically conductive PANI/Sago starch blend prepared by the one-pot synthesis method. Front Mater. 2019; pp. 1-13.
[83]
Thakur G, Mitra A, Basak A, Rousseau D, Pal K. Characterization of oil-in-water gelatin emulsion gels: Effect of homogenization time. Int Conf Systems Med Biol 2010; pp. 305-8.
[84]
Joshi HC, Pandey IP, Kumar A, Gar N. A study of various factors determing the stability of molecules. Adv Pure Appl Chem 2012; 1(1): 7-11.
[85]
Santos HM, Lodeiro C, Capelo-MartRnez JL. The power of ultrasound.
Ultrasound in chemistry: Analytical applications. Weinheim,
Germany: Wiley-Vch Verlag GmbH & Co. KGaA 2009; pp.
1-16.
[89]
Patil S, Patil S, Kavathekar G. Influence of process parameters on compressibility, solubility and release characteristics of melt sonocrystallized fenofibrate. J Pharm Res Int 2016; 1-12.
[94]
Cunha S, Costa CP, Moreira JN, Lobo JS, Silva AC. Using the
Quality by Design (QbD) approach to optimize formulations of lipid
nanopar-ticles and nanoemulsions: A review. Nanomed: Nanotechnol
2020; 1-17.
[98]
Ding Z, Jiang Y, Li X. Nanoemulsions-based drug delivery for brain tumors Nanotechnology-based targeted drug delivery systems for brain tumors. Academic Press 2018; pp. 327-58.
[119]
Eppenbach EG. Combination grinder and homogenizer. US Patent
2357640A, 1944.
[120]
Kinney RR, Pandolfe WD, Ferguson RD. Homogenization valve.
US Patent 5749650, 1998.
[121]
Destefano MS, Cynamon MH, Ziemendorf DW. Sealed grinding
and homogenizing apparatus. US Patent 5829696A, 1998.
[122]
Destefano GA, Mc Namara DP, Jager PD, Jachowicz J. Method
and apparatus for homogenizing aerosol formulations. US Patent
6135628A, 2000.
[123]
Klinksiek B, Mahiout S, Nothelle RC, Hamann J, Sdebik J. Method
and device for producing a parenteral medicament. US Patent
6331314B1, 2001.
[124]
Jarchau M. Homogenization valve with outside high pressure volume.
US Patent 6238080B1, 2001.
[125]
Vergnault G, Grenier P, Nhamias A, Belaredj S, Desset S. Method
for the preparation of pharmaceutical nanosuspensions using supersonic
fluid flow. WO Patent 2003045353A1, 2003.
[126]
Mullar RH, Penkler LJ, Ravelli V, Runge SA. Pharmaceutical
cyclosporin formulation with improved biopharmaceutical properties,
improved physical quality and greater stability, and method for
producing said formulation. EP Patent 1073426B1, 2004.
[127]
Teller J, Westphal F, Gruttner C. Magnetic nanoparticles having
improved magnetic properties. WO Patent 2005006356A1, 2005.
[128]
Werling J, Chaubal M, Kipp J, Rainbow B. Nanosuspensions of
anti-retroviral agents for increased central nervous system delivery
US Patent 20050202094A1, 2005.
[129]
De Castelle RV. Method for the delivery of a biologically active
agent. US Patent 6861066B2, 2005.
[130]
Daiziel S, Gommeren EH, Calabrese R, Friedmann T. Rotor-stator
apparatus and process for the formation of particles. US Patent
20050202095A1, 2005.
[131]
Uesugi M, Tsunofuri M, Nagano J, Mizobudi S. Rotor/stator type
homogenizer. US Patent 6869212B2, 2005.
[132]
Mishra AK, Pace GW, Vachon MG. Injectable aqueous dispersions
of propofol. US Patent 7041705B2, 2006.
[133]
Jiang S, Xianjua W, Liqiang W. Blumea oil liquid capsule and
preparation method thereof. CN Patent 101543520A, 2006.
[134]
Jahn K, Williams T. Combination low-shear mixer and high-shear
homogenizer. US Patent 7052172B2, 2006.
[135]
Gelperina S, Khalanskiy A, Kreuter J, Mksimenko O. Drug delivery
system, useful for supplying active substance to central nervous
system of a mammal over the blood-brain barrier, comprises: Nanoparticles
of poly(DL-lactide-co-glycolide) and pharmaceutical
substance e.g. cytostatic agent. DE Patent 102006013531A1, 2007.
[136]
De Casteele RV, Gerike M. Nanofluidized b-12 composition and
process for treating pernicious anemia. WO Patent 2007103931A2,
2007.
[137]
Bachelier HJ, Boss FR. Homogenising device. EP Patent
1125625B1, 2007.
[138]
Vanderbist F, Baudier P, Pilcer G, Amighi K. Improved pharmaceutical
dry powder compositions for inhalation. WO Patent
2009050217A2, 2009.
[139]
Gill L, Gadzic R, Roytbalt I. Magnetic homogenizer apparatus. US
Patent 20100282099A1, 2010.
[140]
Ray SJ, Gibbins GR. Devices for blending materials and bags and
for use in such devices. US Patent 7789551B2, 2010.
[141]
Gandini M, Grandi S. Homogeniser for the continuous treatment of
fluids at very high pressure. US Patent 7661873B2, 2010.
[142]
Chen MJ, Hui HW, Lee T, Kurtuilk P, Surapaneni S. Nanosuspension
of a oorly soluble drug via microfluidization process. US Patent
20110124702A1, 2011.
[143]
Nakach M. High-pressure homogenization with a silicon nitride
valve. US Patent 20120127823A1, 2012.
[144]
Tang X, Yu Q. Lyophilized formulation of pectin-adriamycin conjugate
and preparation method thereof. US Patent 20130172283A1,
2013.
[145]
Chandavarkar NM, Jindal KC, Malayandi R. Nanodispersion of
poorly water soluble drug(s). WO Patent 2013098841A1, 2013.
[146]
Panagiotou T, Mesite SV, Fisher RJ. Apparatus and methods for
nanoparticle generation and process intensification of transport and
reaction systems. US Patent 8367004B2, 2013.
[147]
Hassan A, Anthony RG, Hassan A. High shear application in drug
delivery. US Patent 8609115B, 2013.
[148]
Wei G, Lee BTK, Zhang W, Lu W, Lau JYN, Lam SCD. Ophthalmic
composition, method for preparing the same, and use of the
same. WO Patent 2014153733A1, 2014.
[149]
Huang J. Stable pharmaceutical composition of clopidogrel free
base for oral and parenteral de-livery. WO Patent 2014124132A1,
2014.
[150]
Edelson J, Nicolosi R. Botulinum nanoemulsions. US Patent
20140099342A1, 2014.
[151]
Yepes HC, Gonzalez LPH. Continuous method for producing nanoparticles
and nanoparticles obtained by means of said method.
US Patent 20140099377A, 2014.
[152]
Benassi M, Bottioni M. High-pressure homogenizer. CA Patent
2894474A1, 2014.
[153]
Yongqiang C. Homogenizing valve with multi-passage nozzle. CN
Patent 203710932U, 2014.
[154]
Vidakovic V, Smith S. Sample-tube cassette and mounting plate for
use with homogenizing device. US Patent 20140293735A1, 2014.
[155]
Botas JP, Goncalves D, Martins D, Neves F, Melo J, Almeida N. Dynamic Suspension Drying (DSD) to control ostwald ripening.
WO Patent 2014108687A1, 2014.
[156]
Repka MA, Patil HG, Majumdar S, Park JB, Kulkarni VI. Systems
and methods for preparing solid lipid nanoparticles. WO Patent
2015148483A1, 2015.
[157]
Pramanick S, Mukund KG, Sumit SM. Pharmaceutical composition
of propofol. EP Patent 2884964A2, 2015.
[158]
Peterson R. Nanocrystals for use in topical cosmetic formulations
and method of production thereof. US Patent 9114077B2, 2015.
[159]
Bahl D, Crowley KJ, Yu D. Oral solid dosage form containing
nanoparticles and process of formulating the same using fish gelatin.
US Patent 9775819B2, 2017.
[160]
Vettorato LF, Assis URS, Cortez LD. Injectable formulation of a
macrocyclic lactone and levamisole. WO Patent 2017108954A1,
2017.
[161]
Unger EC, Martinelli E. Adjusting particle size in fluorocarbon
nanoemulsions. WO Patent 2017031051A1, 2017.
[164]
Patil JS, Dhadde SB, Chandakavathe BN. Characterization and biology of nanomaterials for drug delivery Nanostructure drug delivery system is an option to solve antimicrobial drug resistance: Perspective review. Elsevier 2019; pp. 165-97.
[167]
Nomani MS, Samy JG. Nanoliposome: An alternative approach for drug delivery system. Int J Adv Pharm Med Bioallied Sci 2016; 4(2): 37-46.
[173]
Jaiswal M, Dudhe R, Sharma PK. Nanoemulsion: An advanced
mode of drug delivery system. 3 Biotech 2015; 5(2): 123-7.
[176]
Nagavarma BVN, Yadav HKS, Ayaz A, Vasudha LS, Shivakumar HG. Different techniques for preparation of polymeric nanoparticles- A review. Asian J Pharm Clin Res 2013; 5(3): 16-23.